Skip to main content

Table 1 Patient characteristics by diabetes, ASCVD, HF and kidney disease status

From: Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008–2019

 

Diabetes overall (n = 32,519)

Diabetes w/o cardiorenala (n = 21,290)

Diabetes w/ASCVD (n = 9599)

Diabetes w/HF (n = 952)

Diabetes w/kidney disease (n = 2820)

Sociodemographic and other characteristics, n (%)

Male

14,923 (45.9)

9261 (43.5)

4937 (51.4)

460 (48.3)

1300 (46.1)

Age, mean (SD)

60.5 (14.0)

57.8 (14.0)

66.5 (12.0)

67.1 (12.1)

63 (13.4)

Age 18–44

4415 (13.5)

3745 (17.6)

419 (4.4)

37 (3.9)

284 (10.1)

Age 45–65

14,781 (45.5)

10,441 (49.0)

3594 (37.4)

356 (37.4)

1181 (41.8)

Age > 65

13,323 (41.0)

7104 (33.4)

5586 (58.2)

559 (58.7)

1355 (48.1)

Race/ethnicity: Non-Hispanic Black

5056 (23.8)

7794 (24.0)

2288 (23.9)

294 (30.9)

738 (26.2)

Race/ethnicity: Hispanic

5926 (27.8)

8295 (25.5)

1971 (20.5)

101 (10.6)

640 (22.7)

Race/ethnicity: other

10,308 (48.4)

16,430 (50.5)

5340 (55.6)

557 (58.5)

1442 (51.1)

Married

17,122 (52.7)

11,667 (54.8)

4701 (49.0)

396 (41.6)

1289 (45.7)

Year, 2008–2011

9878 (30.4)

6382 (30.0)

2976 (31.0)

310 (32.6)

883 (31.3)

Year, 2012–2015

11,320 (34.8)

7391 (34.7)

3346 (34.9)

327 (34.4)

1040 (36.9)

Year, 2016–2019

11,321 (34.8)

7517 (35.3)

3277 (34.1)

315 (33.0)

897 (31.8)

Family income: poor

6960 (21.4)

4136 (19.4)

2413 (25.1)

240 (25.2)

773 (27.4)

Family income: near poor

2349 (7.2)

1394 (6.5)

825 (8.6)

77 (8.1)

241 (8.6)

Family income: low income

5777 (17.8)

3658 (17.2)

1785 (18.6)

190 (20.0)

574 (20.4)

Family income: middle income

9379 (28.8)

6312 (29.7)

2625 (27.4)

262 (27.5)

753 (26.6)

Family income: high income

8054 (24.8)

5790 (27.2)

1951 (20.3)

183 (19.2)

479 (17.0)

Region: Northeast

5054 (15.5)

3242 (15.2)

1641 (17.1)

109 (11.5)

327 (11.6)

Region: West

7579 (23.3)

5372 (25.2)

1797 (18.7)

157 (16.5)

466 (16.5)

Region: Midwest

6035 (18.6)

3847 (18.1)

1910 (19.9)

249 (26.2)

1361 (48.3)

Region: South

13,851 (42.6)

8829 (41.5)

4251 (44.3)

437 (45.8)

666 (23.6)

Insurance coverage: Public only

13,623 (41.9)

7589 (35.7)

5201 (54.2)

548 (57.6)

1574 (55.8)

insurance coverage: any private

15,982 (49.1)

11,397 (53.5)

3927 (40.9)

368 (38.6)

1047 (37.1)

Insurance coverage: uninsured

2914 (9.0)

2304 (10.8)

471 (4.9)

36 (3.8)

199 (7.1)

Comorbid conditions, n (%)

ASCVD

9599 (29.5)

NA

NA

718 (75.4)

1371 (48.6)

Myocardial infarction

3936 (12.1)

NA

3936 (41.0)

369 (38.8)

606 (21.5)

Stroke

3819 (11.7)

NA

3819 (39.8)

276 (29.0)

617 (21.9)

Angina

2451 (7.5)

NA

2451 (25.5)

223 (23.4)

410 (14.5)

Heart failure

952 (2.9)

NA

718 (7.5)

NA

227 (8.1)

Kidney disease

2820 (8.7)

NA

1371 (14.3)

227 (23.8)

NA

Arthritis

16,358 (50.3)

9185 (43.1)

6234 (64.9)

667 (70.1)

1848 (65.5)

Chronic obstructive pulmonary disease

3156 (9.7)

1313 (6.2)

1641 (17.1)

272 (28.6)

468 (16.6)

Asthma

4662 (14.3)

2619 (12.3)

1791 (18.7)

222 (23.3)

517 (18.3)

high cholesterol

23,071 (71.0)

13,831 (65.0)

7981 (83.1)

779 (81.8)

2311 (82.0)

Cancer

5132 (15.8)

2688 (12.6)

2158 (22.5)

235 (24.7)

600 (21.3)

Depression

4827 (14.8)

2686 (12.6)

1839 (19.2)

253 (26.6)

557 (19.8)

Healthcare spending, mean (SE)b

Overall costs

13,829 (213)

9844 (196)

21,542 (501)

32,654 (1571)

26,652 (1060)

Medical costs

9301 (172)

6203 (153)

15,372 (400)

24,837 (1,465)

18,844 (779)

Prescription costs

4528 (98)

3642 (113)

6170 (180)

7817 (476)

7808 (495)

  1. ASCVD, atherosclerotic cardiovascular disease; HF, heart failure
  2. aComorbidities of interest were ASCVD, HF, and kidney disease
  3. bAnalyses were not adjusted for covariates. Survey weights and procedures were utilized. See text for details on ascertainment of spending and definitions of cardiorenal conditions